相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The human ACE-2 receptor binding domain of SARS-CoV-2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate
Bo-Kyoung Jung et al.
PLOS ONE (2022)
The phosphatase and tensin homolog gene inserted between NP and P gene of recombinant New castle disease virus oncolytic effect test to glioblastoma cell and xenograft mouse model
Sung Hoon Jang et al.
VIROLOGY JOURNAL (2022)
Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
Sara Shayan et al.
CANCER CELL INTERNATIONAL (2022)
Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
Fang Huang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Endoscopic diagnosis and treatment of early colorectal cancer
Seung Wook Hong et al.
INTESTINAL RESEARCH (2022)
Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
Liu Tianyan et al.
GENE THERAPY (2021)
Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
Ahmed Malki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes
Lee-Chin Chan et al.
BMC CANCER (2021)
Newcastle-disease-virus-induced ferroptosis through nutrient deprivation and ferritinophagy in tumor cells
Xianjin Kan et al.
ISCIENCE (2021)
The limiting factors of oncolytic virus immunotherapy and the approaches to overcome them
Pei-Yang Hu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxe1nu nude mice
Syed Umar Faruq Syed Najmuddin et al.
PEERJ (2020)
Perspectives on immunotherapy via oncolytic viruses
Alberto Reale et al.
INFECTIOUS AGENTS AND CANCER (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Nuclear localization of Newcastle disease virus matrix protein promotes virus replication by affecting viral RNA synthesis and transcription and inhibiting host cell transcription
Zhiqiang Duan et al.
VETERINARY RESEARCH (2019)
Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model
Kseniya S. Yurchenko et al.
PLOS ONE (2018)
Virus Infection and Death Receptor-Mediated Apoptosis
Xingchen Zhou et al.
VIRUSES-BASEL (2017)
RIP1 is a central signaling protein in regulation of TNF-α/TRAIL mediated apoptosis and necroptosis during Newcastle disease virus infection
Ying Liao et al.
ONCOTARGET (2017)
Proinflammatory response induced by Newcastle disease virus in tumor and normal cells
Teridah Ernala Ginting et al.
ONCOLYTIC VIROTHERAPY (2017)
MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer
Young Ran Park et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect
Ziye Pan et al.
PLOS ONE (2016)
Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy
Jinjiao He et al.
VIRUS RESEARCH (2016)
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Prostate Cancer Cells after Treatment with Xanthohumol-A Natural Compound Present in Humulus lupulus L.
Malgorzata Klosek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
The therapeutic effect of death: Newcastle disease virus and its antitumor potential
Sara Cuadrado-Castano et al.
VIRUS RESEARCH (2015)
P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression
Wei Zhao et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Results on efficacy and safety of cancer treatment with or without tumor necrosis factor-related apoptosis-inducing ligand-related agents: A meta-analysis
Shaoxing Sun et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
NDV-induced apoptosis in absence of Bax; evidence of involvement of apoptotic proteins upstream of mitochondria
Aidin Molouki et al.
VIROLOGY JOURNAL (2012)
Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung Cancer
Jean-Charles Soria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Newcastle Disease Virus Infection Promotes Bax Redistribution to Mitochondria and Cell Death in HeLa Cells
Aidin Molouki et al.
INTERVIROLOGY (2010)
Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer
Jean-Charles Soria et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo
Laura Formentini et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
Dmitriy Zamarin et al.
MOLECULAR THERAPY (2009)
Cancer in inflammatory bowel disease
Jianlin Xie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
History of oncolytic viruses: Genesis to genetic engineering
Elizabeth Kelly et al.
MOLECULAR THERAPY (2007)
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus
Robert M. Lorence et al.
CURRENT CANCER DRUG TARGETS (2007)
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
AI Freeman et al.
MOLECULAR THERAPY (2006)
Induction of interferon-α and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus
JY Zeng et al.
VIROLOGY (2002)
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
AL Pecora et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site
R Takimoto et al.
ONCOGENE (2000)
Newcastle disease virus (NDV): brief history of its oncolytic strains
JG Sinkovics et al.
JOURNAL OF CLINICAL VIROLOGY (2000)
分享论文
